KATHRYN PENN: Open Payments
NPI 1295011377 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $67 |
| Novo Nordisk Inc | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $34 |
| Lundbeck LLC | 2 | $33 |
| PFIZER INC. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $14 |
| Abbott Laboratories | 1 | $14 |
Products named: Ozempic, MOUNJARO, GVOKE HYPOPEN, QULIPTA, VYEPTI, PREVNAR 20, INSPIRE, ZEPBOUND.
Industry payments across MD — which companies pay providers there.
